Market Overview:
The global 3D diagnostic imaging services market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for 3D diagnostic imaging services due to the rising prevalence of chronic diseases and technological advancements in 3D diagnostic imaging equipment. Based on type, the global 3D diagnostic imaging services market is segmented into ultrasound, MRI, X-ray, computed tomography (CT), and others. The ultrasound segment is expected to account for the largest share of the global 3D diagnostic imaging services market in 2018 owing to its low cost and high accuracy. Based on application, the global 3D diagnostic imaging services market is segmented into oncology, cardiology, orthopedic surgery, and others.
Product Definition:
3D Diagnostic Imaging Services is the use of three-dimensional images to diagnose medical conditions. 3D diagnostic imaging services are important because they can provide a more accurate diagnosis of medical conditions than traditional two-dimensional images.
Ultrasound:
Ultrasound is a form of non-ionizing radiation used for imaging. It helps in creating high-resolution images of internal body structures with the help of sound waves. The ultrasound imaging devices produce two beams of ultrasonic vibrations, which are applied to the skin and then converted into an image by a transducer on the screen.
MRI:
Magnetic Resonance Imaging (MRI) is a diagnostic medical device that generates magnetic fields and radio waves to produce images of body tissues. MRI works by detecting the hydrogen nuclei in the body tissues which are linked to certain acids. When these nuclei absorb the electromagnetic radiation, they change shape and energy levels, which can be detected by sensors placed around them.
Application Insights:
On the basis of application, the global 3D diagnostic imaging services market is segmented into oncology, cardiology, orthopedic and others. The orthopedic segment held a significant share in 2017 owing to increasing prevalence of diseases such as arthritis and bone disorders. According to WHO, around 300 million people are suffering from arthritis worldwide. Moreover, this disease impacts more than 10% of the total population of Europe and North America. As per Arthritis Foundation estimates around 54 million Americans have some form of arthritis or rheumatic condition while 26 million have very severe forms which require long-term care facility or hospitalization due to pain and other symptoms like limited mobility or disability caused by arthritic conditions. This growing prevalence coupled with rising geriatric population group susceptible to various forms of joint disorder is expected fuel demand for advanced diagnostics techniques such as 3D ultrasound during the forecast period thereby contributing towards overall revenue growth in near future years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies and favorable reimbursement scenario. The U.S., which is at the forefront, has a well-developed healthcare infrastructure and is one of the most lucrative markets for medical devices as well as diagnostic imaging services providers globally.
Asia Pacific region is expected to witness lucrative growth over the forecast period owing to increasing government initiatives for improving healthcare facilities coupled with rising awareness regarding early diagnosis in emerging economies such as China and India are some factors attributing toward this growth. Moreover, economic development in these countries has enabled people with greater disposable income which will further boost demand during forecast period (2018 - 2030).
Growth Factors:
- Increasing demand for 3D diagnostic imaging services due to technological advancements in the field of medical diagnostics.
- Rising prevalence of chronic diseases and disorders that require advanced diagnostic imaging for accurate diagnosis and treatment planning.
- Growing number of private clinics and hospitals offering 3D diagnostic imaging services as a part of their radiology departments.
- Increasing awareness about the benefits of 3D diagnostic imaging among healthcare professionals and patients alike.
Scope Of The Report
Report Attributes
Report Details
Report Title
3D Diagnostic Imaging Services Market Research Report
By Type
Ultrasound, MRI, X-ray, Computed Tomography, Others
By Application
Oncology, Cardiology, Orthopedic, Others
By Companies
America Holdings, Quest Diagnostics, Alere, Bio-Reference Laboratories, Optum, Genomic Health, Myriad Genetics, NeoGenomics, Sonic Healthcare, Spectra Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global 3D Diagnostic Imaging Services Market Report Segments:
The global 3D Diagnostic Imaging Services market is segmented on the basis of:
Types
Ultrasound, MRI, X-ray, Computed Tomography, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Cardiology, Orthopedic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- America Holdings
- Quest Diagnostics
- Alere
- Bio-Reference Laboratories
- Optum
- Genomic Health
- Myriad Genetics
- NeoGenomics
- Sonic Healthcare
- Spectra Laboratories
Highlights of The 3D Diagnostic Imaging Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ultrasound
- MRI
- X-ray
- Computed Tomography
- Others
- By Application:
- Oncology
- Cardiology
- Orthopedic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the 3D Diagnostic Imaging Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
3D diagnostic imaging services are a type of medical imaging that uses three dimensions (height, width, and depth) to create images. This technology can be used to view organs and other body parts in detail. 3D diagnostic imaging services can also be used to diagnose medical conditions.
Some of the key players operating in the 3d diagnostic imaging services market are America Holdings, Quest Diagnostics, Alere, Bio-Reference Laboratories, Optum, Genomic Health, Myriad Genetics, NeoGenomics, Sonic Healthcare, Spectra Laboratories.
The 3d diagnostic imaging services market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 3D Diagnostic Imaging Services Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 3D Diagnostic Imaging Services Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 3D Diagnostic Imaging Services Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the 3D Diagnostic Imaging Services Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global 3D Diagnostic Imaging Services Market Size & Forecast, 2018-2028
4.5.1 3D Diagnostic Imaging Services Market Size and Y-o-Y Growth
4.5.2 3D Diagnostic Imaging Services Market Absolute $ Opportunity
Chapter 5 Global 3D Diagnostic Imaging Services Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 3D Diagnostic Imaging Services Market Size Forecast by Type
5.2.1 Ultrasound
5.2.2 MRI
5.2.3 X-ray
5.2.4 Computed Tomography
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global 3D Diagnostic Imaging Services Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 3D Diagnostic Imaging Services Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Cardiology
6.2.3 Orthopedic
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global 3D Diagnostic Imaging Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 3D Diagnostic Imaging Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America 3D Diagnostic Imaging Services Analysis and Forecast
9.1 Introduction
9.2 North America 3D Diagnostic Imaging Services Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America 3D Diagnostic Imaging Services Market Size Forecast by Type
9.6.1 Ultrasound
9.6.2 MRI
9.6.3 X-ray
9.6.4 Computed Tomography
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America 3D Diagnostic Imaging Services Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Cardiology
9.10.3 Orthopedic
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe 3D Diagnostic Imaging Services Analysis and Forecast
10.1 Introduction
10.2 Europe 3D Diagnostic Imaging Services Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe 3D Diagnostic Imaging Services Market Size Forecast by Type
10.6.1 Ultrasound
10.6.2 MRI
10.6.3 X-ray
10.6.4 Computed Tomography
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe 3D Diagnostic Imaging Services Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Cardiology
10.10.3 Orthopedic
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific 3D Diagnostic Imaging Services Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific 3D Diagnostic Imaging Services Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific 3D Diagnostic Imaging Services Market Size Forecast by Type
11.6.1 Ultrasound
11.6.2 MRI
11.6.3 X-ray
11.6.4 Computed Tomography
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific 3D Diagnostic Imaging Services Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Cardiology
11.10.3 Orthopedic
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America 3D Diagnostic Imaging Services Analysis and Forecast
12.1 Introduction
12.2 Latin America 3D Diagnostic Imaging Services Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America 3D Diagnostic Imaging Services Market Size Forecast by Type
12.6.1 Ultrasound
12.6.2 MRI
12.6.3 X-ray
12.6.4 Computed Tomography
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America 3D Diagnostic Imaging Services Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Cardiology
12.10.3 Orthopedic
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) 3D Diagnostic Imaging Services Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) 3D Diagnostic Imaging Services Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) 3D Diagnostic Imaging Services Market Size Forecast by Type
13.6.1 Ultrasound
13.6.2 MRI
13.6.3 X-ray
13.6.4 Computed Tomography
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) 3D Diagnostic Imaging Services Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Cardiology
13.10.3 Orthopedic
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 3D Diagnostic Imaging Services Market: Competitive Dashboard
14.2 Global 3D Diagnostic Imaging Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 America Holdings
14.3.2 Quest Diagnostics
14.3.3 Alere
14.3.4 Bio-Reference Laboratories
14.3.5 Optum
14.3.6 Genomic Health
14.3.7 Myriad Genetics
14.3.8 NeoGenomics
14.3.9 Sonic Healthcare
14.3.10 Spectra Laboratories
